| Drug name |
Drug type |
Disease/phenotype |
Mechanism of action(MoA) |
Phase |
Status |
Source |
| VB-201 | Small molecule | ulcerative colitis | Toll-like receptor 2 inhibitor | 2.0 | Completed | ClinicalTrials |
| VB-201 | Small molecule | COVID-19 | Toll-like receptor 2 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| TOMARALIMAB | Antibody | myelodysplastic syndrome | Toll-like receptor 2 antagonist | 1.0 | Completed | ClinicalTrials |
| VB-201 | Small molecule | psoriasis | Toll-like receptor 2 inhibitor | 2.0 | Completed | ClinicalTrials |